Company Search:
Advanced Search
Sponsored Links
Veloxis Pharmaceuticals A/S Company Snapshot
Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other miscellaneous service companies in Europe: Midatech Pharma PLC of the United Kingdom (2016 sales of £6.92 million [US$9.55 million] of which 81% was Commercial), Carbios Sasu of France (8.87 million Euro [US$10.87 million] ), and Evolva Holding SA which is based in Switzerland (9.58 million Swiss Francs [US$9.97 million] of which 100% was Novel Food Nutritional & Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Veloxis Pharmaceuticals A/S
  Stock Performance Chart for Veloxis Pharmaceuticals A/S
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .89
(Figures in Danish Kroner)
1 Week -0.1%   13 Weeks -1.8%  
4 Weeks -5.9%   52 Weeks -26.5%  
Veloxis Pharmaceuticals A/S Key Data:
  Ticker: VELO Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 62,000,107
(Year Ending Jan 2017).
Employees: 54
  Currency: Danish Kroner Market Cap: 1,519,739,838
  Fiscal Yr Ends: December Shares Outstanding: 1,709,493,631
  Share Type: Stammaktie Closely Held Shares: 732,729,268
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.